ETNK1 mutations are recurrent in leukemia but how they contribute to oncogenesis is still unclear. Here. the authors show that ETNK1 mutations increase mitochondrial activity. ROS and H2AX levels and that these effects can be rescued upon phosphoethanolamine supplementation. https://spencertifieders.shop/product-category/collectable-coins/